# Lu Yoh-Chie

> Lu Yoh-Chie is a seed investor at Biosensors backing Medical and Health Care. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Biosensors](https://shizune.co/investors/profile/biosensors)
- Total investments: 2
- Last investment: Dec 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/lu-yoh-chie-703109

Lu Yoh-Chie is a seed investor at Biosensors focused on Medical and Health Care. Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.

## Contacts

5 contacts available for Lu Yoh-Chie: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/lu-yoh-chie?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 2 | 100% |
| Artificial Intelligence | 2 | 100% |
| mHealth | 1 | 50% |
| Mobile Apps | 1 | 50% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bot MD | Bot MD is an AI assistant for doctors. They provide hospital information to provide instant answers to doctor queries and help automate patient care. Their hospital information systems provide instant answers to call rosters, hospital directories, guidelines, drugs, and HR leave policies. | $5M | Series A | Dec 22, 2020 |  |
| BioTrillion | We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI | $2.3M | Seed | Aug 15, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [Monk’s Hill Ventures](https://shizune.co/investors/profile/monk-s-hill-ventures) — VC Fund, 2 deals together
- [SVTC + Constellar Ventures](https://shizune.co/investors/profile/constellar-ventures) — VC Fund, 1 deal together
- [JG Digital Equity Ventures](https://shizune.co/investors/profile/jg-digital-equity-ventures) — VC Fund, 1 deal together
- [SeaX Ventures](https://shizune.co/investors/profile/seax-ventures) — VC Fund, 1 deal together
- [SGInnovate](https://shizune.co/investors/profile/sginnovate) — VC Fund, 1 deal together
- [XA Network](https://shizune.co/investors/profile/xoogler-angels) — VC Fund, 1 deal together

## About Biosensors

VC Fund · Tokyo, Japan

The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.

1 contacts available at Biosensors.

| Name | Title | Profile |
| --- | --- | --- |
| Lu Yoh-Chie | Founder, Chairman & CEO | https://shizune.co/investors/profile/lu-yoh-chie |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Lu Yoh-Chie invest in?

Lu Yoh-Chie invests primarily in Medical, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Lu Yoh-Chie?

Public channels for Lu Yoh-Chie include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Lu Yoh-Chie last invest?

The most recent investment recorded for Lu Yoh-Chie closed in Dec 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co